ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease

Janine E Bullard1, Susan E Wert, Lawrence M Nogee

  • 1Division of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Seminars in Perinatology
|December 5, 2006
PubMed

Insights

Mutations in the ABCA3 gene cause severe neonatal respiratory disease and interstitial lung disease in children. This review covers clinical, genetic, and pathologic features of ABCA3-related lung disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Pulmonology

Background:

  • ABCA3 is an ATP Binding Cassette transporter protein.
  • ABCA3 mutations are linked to severe neonatal respiratory disease.
  • ABCA3 mutations are also associated with childhood interstitial lung disease.

Purpose of the Study:

  • To review clinical, genetic, and pathologic features of ABCA3-related lung disease.
  • To discuss other childhood interstitial lung diseases with neonatal antecedents and potential genetic bases.

Main Methods:

  • Literature review of ABCA3 gene mutations and associated lung diseases.
  • Summary of clinical presentations, genetic findings, and pathology.
  • Comparative review of other neonatal-onset childhood interstitial lung diseases.

Main Results:

  • ABCA3 mutations present with diverse respiratory phenotypes in neonates and older children.
  • Specific mutations correlate with distinct clinical and pathological findings.
  • Genetic factors play a significant role in various childhood interstitial lung diseases.

Conclusions:

  • ABCA3 mutations are a significant cause of inherited lung disease in children.
  • Understanding ABCA3's role is crucial for diagnosing and managing pediatric lung conditions.
  • Further research into genetic lung diseases in neonates is warranted.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...